Log In
Print
BCIQ
Print
Print this Print this
 

Stedivaze, apadenoson

  Manage Alerts
Collapse Summary General Information
Company Adenosine Therapeutics LLC
DescriptionAdenosine A2A receptor agonist (ADORA2A)
Molecular Target Adenosine A2A receptor (ADORA2A)
Mechanism of ActionAdenosine A2A receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard Indication Cardiovascular (unspecified)
Indication DetailsFor use as a pharmacologic stress agent for myocardial perfusion imaging (MPI)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today